<< Back To Search

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
This is a medical study for testing a new treatment, where all participants will get the treatment. It will also include a safety check phase to make sure it's safe.
*Third Opinion AI Generated Synopsis

Trial Summary
This is a single-arm, open-label phase II study with a safety lead-in phase.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?